Teligent Total Non-Operating Income/Expense 2010-2021 | TLGT

Teligent total non-operating income/expense from 2010 to 2021. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
Teligent Annual Total Non-Operating Income/Expense
(Millions of US $)
2020 $20
2019 $-17
2018 $-21
2017 $-3
2016 $-14
2015 $10
2014 $2
2013 $-0
2012 $-1
2011 $-0
2010 $-0
2009 $-1
Teligent Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2021-06-30 $-2
2021-03-31 $11
2020-12-31 $30
2020-09-30 $8
2020-06-30 $-10
2020-03-31 $-9
2019-12-31 $1
2019-09-30 $-7
2019-06-30 $-5
2019-03-31 $-6
2018-12-31 $-9
2018-09-30 $-3
2018-06-30 $-8
2018-03-31 $-1
2017-12-31 $-1
2017-09-30 $-1
2017-06-30 $1
2017-03-31 $-2
2016-12-31 $-6
2016-09-30 $-3
2016-06-30 $-4
2016-03-31 $-2
2015-12-31 $-4
2015-09-30 $-3
2015-06-30 $11
2015-03-31 $5
2014-12-31 $2
2014-09-30 $-0
2014-06-30 $-0
2014-03-31 $-0
2013-12-31 $-0
2013-09-30 $-0
2013-06-30 $-0
2013-03-31 $-0
2012-12-31 $-0
2012-09-30 $-1
2012-06-30 $-0
2012-03-31 $-0
2011-12-31 $-0
2011-09-30 $-0
2011-06-30 $-0
2011-03-31 $-0
2010-12-31 $-0
2010-09-30 $-0
2010-06-30 $0
2010-03-31 $0
2009-12-31 $0
2009-09-30 $0
2009-06-30 $-1
2009-03-31 $-0
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.679B 6.46
Dr Reddy's Laboratories (RDY) India $12.521B 23.96
BridgeBio Pharma (BBIO) United States $4.911B 0.00
Bausch Health Cos (BHC) Canada $3.439B 2.49
Amphastar Pharmaceuticals (AMPH) United States $2.335B 14.04
Supernus Pharmaceuticals (SUPN) United States $2.022B 27.53
Taysha Gene Therapies (TSHA) United States $0.334B 54.33
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.104B 0.00
Sol-Gel Technologies (SLGL) Israel $0.015B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00